Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - THERALINK TECHNOLOGIES, INC.Financial_Report.xls
10-K - ANNUAL REPORT - THERALINK TECHNOLOGIES, INC.form10k.htm
EX-32.2 - CERTIFICATION - THERALINK TECHNOLOGIES, INC.exhibit32-2.htm
EX-31.1 - CERTIFICATION - THERALINK TECHNOLOGIES, INC.exhibit31-1.htm
EX-31.2 - CERTIFICATION - THERALINK TECHNOLOGIES, INC.exhibit31-2.htm
EX-10.40 - ASSET PURCHASE AGREEMENT - THERALINK TECHNOLOGIES, INC.exhibit10-40.htm
EX-10.41 - CO-PROMOTION AGREEMENT - THERALINK TECHNOLOGIES, INC.exhibit10-41.htm
EX-10.43 - PROMISSORY NOTE AMENDMENT - THERALINK TECHNOLOGIES, INC.exhibit10-43.htm
EX-10.42 - PROMISSORY NOTE AMENDMENT - THERALINK TECHNOLOGIES, INC.exhibit10-42.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Cameron Durrant, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that

1.

the annual report on Form 10-K of PediatRx Inc. for the period ended February 29, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

   
2.

the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of PediatRx Inc.

May 18, 2012

  /s/Cameron Durrant
  Cameron Durrant
  President, Chief Executive Officer and Director
  (Principal Executive Officer)